News | September 12, 2011

Life Recovery Systems Earns Three-Year Agreement For Distribution of ThermoSuit System

September 12, 2011 — Life Recovery Systems (LRS) announced it has been awarded a new three-year agreement by Premier Purchasing Partners LP (PPP), the group purchasing unit of the Premier healthcare alliance. PPP makes the ThermoSuit system available by contract to its more than 75,000 healthcare member facilities.

The award is LRS’s first group purchasing organization (GPO) contract. The agreement for patient temperature management products and accessories runs from July 1, 2011 until June 30, 2014.

Lafayette General Hospital in Lafayette, La., a Premier member hospital, has been using the ThermoSuit system since 2010. Elizabeth Weber, ICU clinical educator at Lafayette General commented, "The ThermoSuit System is fast and easy to use and we have had a number of positive outcomes with minimal or no neurological impairment."

The system uses direct liquid contact with the patient to reduce core body temperature. A thin film of ice water is circulated over the patient's body until the temperature reaches a pre-set limit, at which point the water is automatically removed from the suit. Two nurses or techs easily set up the system in about seven minutes. It cools to a therapeutic temperature of 33 degrees C in 20 to 30 minutes. The patient is then removed from the suit and remains cold for hours without further maintenance, allowing unencumbered access for imaging or treatment in the cath lab.

Patients can also be cooled in remote satellite hospitals and shipped cool to larger hospitals with specialized cardiac care facilities. After this, further maintenance and rewarming can be accomplished using a regular cooling blanket.

Robert Schock, M.D., LRS’s vice president of research and development and co-inventor of the Thermosuit system said, "The ThermoSuit system has been designed to harness the speed and efficiency of ice water immersion in a medical device which uses a small volume of water and is safe and easy to use in a medical facility."

For more information: www.life-recovery.com

 

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init